TY - JOUR
T1 - Ceramide synthase mediates daunorubicin-induced apoptosis
T2 - An alternative mechanism for generating death signals
AU - Bose, Ron
AU - Verheij, Marcel
AU - Haimovitz-Friedman, Adriana
AU - Scotto, Kathleen
AU - Fuks, Zvi
AU - Kolesnick, Richard
N1 - Funding Information:
Correspondence should be addressed to R. K. The authors would like to thank Ashish Patel for his contribution to these studies. These investigations were supported by grants CA42385 and CA57400 to R. K, and grant CA52462 to Z. F. from the National Institutes of Health. R. B. was supported by Medical Scientist Training Program training grant GM07739 and the Lee Friedman Memorial Fellowship. M. V. was supported by a fellowship from the Dutch Cancer Society (Koningin Wilhelmina Fonds).
PY - 1995/8/11
Y1 - 1995/8/11
N2 - The sphingomyelin pathway, which is initiated by sphingomyelin hydrolysisto generate the second messenger ceramide, signals apoptosis for tumor necrosis factor α, Fas, and ionizing radiation. In the present studies, the anticancer drug daunorubicin also stimulated ceramide elevation and apoptosis in P388 and U937 cells. Cell-permeable analogs of ceramide, but not other lipid second messengers, mimicked daunorubicin in inducing apoptosis. Daunorubicin-stimulated ceramide elevation, however, did not result from sphingomyelin hydrolysis, but rather from de novo synthesis via activation of the enzyme ceramide synthase. An obligatory role for ceramide synthase was defined, since its natural specific inhibitor, fumonisin B1, blocked daunorubicin-induced ceramide elevation and apoptosis. These studies demonstrate that ceramide synthase activity can be regulated in eukaryotes and constitute definitive evidence for a requirement for ceramide elevation in the induction of apoptosis.
AB - The sphingomyelin pathway, which is initiated by sphingomyelin hydrolysisto generate the second messenger ceramide, signals apoptosis for tumor necrosis factor α, Fas, and ionizing radiation. In the present studies, the anticancer drug daunorubicin also stimulated ceramide elevation and apoptosis in P388 and U937 cells. Cell-permeable analogs of ceramide, but not other lipid second messengers, mimicked daunorubicin in inducing apoptosis. Daunorubicin-stimulated ceramide elevation, however, did not result from sphingomyelin hydrolysis, but rather from de novo synthesis via activation of the enzyme ceramide synthase. An obligatory role for ceramide synthase was defined, since its natural specific inhibitor, fumonisin B1, blocked daunorubicin-induced ceramide elevation and apoptosis. These studies demonstrate that ceramide synthase activity can be regulated in eukaryotes and constitute definitive evidence for a requirement for ceramide elevation in the induction of apoptosis.
UR - http://www.scopus.com/inward/record.url?scp=0029148660&partnerID=8YFLogxK
U2 - 10.1016/0092-8674(95)90429-8
DO - 10.1016/0092-8674(95)90429-8
M3 - Article
C2 - 7634330
AN - SCOPUS:0029148660
SN - 0092-8674
VL - 82
SP - 405
EP - 414
JO - Cell
JF - Cell
IS - 3
ER -